Somnomed Ltd
F:RJV

Watchlist Manager
Somnomed Ltd Logo
Somnomed Ltd
F:RJV
Watchlist
Price: 0.404 EUR 1.51% Market Closed
Market Cap: 87.3m EUR
Section:
Wall Street Price Targets
Wall Street Price Targets
Revenue Forecast
Operating Income Forecast
Net Income Forecast
See Also
Price Target
Average
+18%
Revenue
Forecast
+13%
Operating Income
Forecast
N/A
Net Income
Forecast
N/A

Wall Street
Price Targets

RJV Price Targets Summary
Somnomed Ltd

Wall Street analysts forecast RJV stock price to rise over the next 12 months.

According to Wall Street analysts, the average 1-year price target for RJV is 0.479 EUR with a low forecast of 0.421 EUR and a high forecast of 0.547 EUR.

RJV Lowest Forecast
Wall Street Target
0.421 EUR
4% Upside
RJV Average Forecast
Wall Street Target
0.479 EUR
18% Upside
RJV Highest Forecast
Wall Street Target
0.547 EUR
35% Upside
Lowest
Price Target
0.421 EUR
4% Upside
Average
Price Target
0.479 EUR
18% Upside
Highest
Price Target
0.547 EUR
35% Upside
Somnomed Ltd Competitors:
Price Targets
SHL
Siemens Healthineers AG
31% Upside
LIVN
LivaNova PLC
15% Upside
DEMANT
Demant A/S
24% Upside
E
ELMD
Electromed Inc
36% Upside
SHL
Siemens Healthineers AG
31% Upside
LIVN
LivaNova PLC
15% Upside
DEMANT
Demant A/S
24% Upside
E
ELMD
Electromed Inc
36% Upside
KRMD
Repro Med Systems Inc
34% Upside
L
2291
Lepu Scientech Medical Technology Shanghai Co Ltd
25% Upside
6609
Shanghai HeartCare Medical Technology Corp Ltd
59% Downside
853
Microport Scientific Corp
7% Downside

Revenue
Forecast

Revenue Estimate
Somnomed Ltd

For the last 8 years the compound annual growth rate for Somnomed Ltd's revenue is 10%. The projected CAGR for the next 3 years is 13%.

10%
Past Growth
13%
Estimated Growth
Estimates Accuracy
-2%
Average Miss
What are analyst estimates?

Operating Income
Forecast

Operating Income Estimate
Somnomed Ltd

N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
7%
Average Beat
What are analyst estimates?

Net Income
Forecast

Net Income Estimate
Somnomed Ltd

N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
-51%
Average Miss
What are analyst estimates?

See Also

Summary
RJV intrinsic value, competitors valuation, and company profile.
DCF Valuation
RJV stock valuation using Discount Cash Flow valuation method.
Relative Valuation
RJV stock valuation using valuation multiples.
Wall Street Estimates
RJV price targets and financial estimates made by Wall st analysts.
Profitability Analysis
Detailed analysis of the company's profitability.
Solvency Analysis
Analysis of the financial position and solvency of the company.
Financials
Income Statement, Balance Sheet, Cash Flow Statement.
Discount Rate
RJV stock discount rate: cost of equity and WACC.
Summary
DCF Valuation
Relative Valuation
Wall Street Estimates
Profitability Analysis
Solvency Analysis
Financials
Discount Rate
Discover More
Why do you have more estimates than other sites?

Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What is available on other sites you are seeing are mostly from the sell-side analysts.

What is RJV's stock price target?
Price Target
0.479 EUR

According to Wall Street analysts, the average 1-year price target for RJV is 0.479 EUR with a low forecast of 0.421 EUR and a high forecast of 0.547 EUR.

What is Somnomed Ltd's Revenue forecast?
Projected CAGR
13%

For the last 8 years the compound annual growth rate for Somnomed Ltd's revenue is 10%. The projected CAGR for the next 3 years is 13%.

Back to Top
ALPHA SPREAD
Follow us
Join more than 278,100+ value investors using Alpha Spread
Create Free Account
or see our plans & pricing

Company

About Us Careers Pricing Affiliate Program Terms of Service Privacy Policy

Help

What is Intrinsic Value? Help Center Contact Us

Tools

Stock Screener Intrinsic Value Calculator DCF Value Calculator Discount Rate Calculator

Stocks

Most Undervalued Stocks Wide Economic Moat Stocks High Profitability Stocks High Solvency Stocks Most Popular Stocks

© 2025 Alpha Spread Limited. All Rights Reserved.

www.alphaspread.com is not operated by a broker, a dealer, or a registered investment adviser. Under no circumstances does any information posted on www.alphaspread.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute, investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. In no event shall Alpha Spread Limited be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on www.alphaspread.com, or relating to the use of, or inability to use, www.alphaspread.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance.